Paul Szabolcs
3 clinical trials · 3 recruiting · OTHER
Trials by Paul Szabolcs
RECRUITINGPhase 2NCT03630211
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published...
Sponsor: Paul SzabolcsEnrolling: 83 locations
Systemic SclerosisDiffuse Sclerosis SystemicInterstitial Lung Disease+1
RECRUITINGNCT04528355
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
This is a data collection study that will examine the general diagnostic and treatment data associated with the reduced-intensity chemotherapy-based regimen paired with simple...
Sponsor: Paul SzabolcsEnrolling: 501 location
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2
RECRUITINGPhase 2NCT01962415
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched...
Sponsor: Paul SzabolcsEnrolling: 1001 location
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4